Business Wire

NuID Launches Ecosystem Fuelled by Kii Token to Empower Users with the Right to Control Their Digital Identity

Share

NuID, a decentralized identity and authentication solution, today announced the launch of the Nu Identity (NuID) Ecosystem.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220919005148/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

NuID CEO & Founder, Locke Brown (Photo: Business Wire)

The ecosystem will provide internet users with the ability to own and control their digital identity by using services built upon NuID’s foundational zero-knowledge authentication solution.

The Nu Identity Ecosystem is powered by Kii, a new utility token – the public sale of which will commence today. The company is using LATOKEN as the launchpad for its IEO and will launch the token in partnership with The Kii Foundation.

Kii token holders will be the first to access the NuID ecosystem, which empowers users to choose what identifying data they want to share on the web, and to whom they share it. Token holders can use Kii to register their authentication credentials on a public blockchain, issue data attestations, access future identity use cases within the ecosystem and more. This includes and is not limited to KYC and identity verification, credential issuance, healthcare records, digitized assets, education credentials, verified claims, and decentralized data storage.

“Such an ecosystem will provide users the ability to own, control, and permit the use of identity-related data efficiently and allow businesses to become ‘consumers' of these identities and their associated metadata vs. the other way around. This in turn will increase the volume of more privacy-centric interactions on the web,” said Locke Brown, CEO and founder at NuID.

“We are flipping the data ownership dynamic, which benefits users and services. Companies don’t have to secure huge amounts of user data and users no longer have to share their sensitive, identifying information. In the next few years, vast amounts of personal data and credentials will be represented on a blockchain by a public identifier that reveals no user data, and cannot be backwards solved for the original secret," adds Ibrahim Pataudi VP Business Development at NuID.

To learn more about NuID please visit: www.nuid.io

Disclaimer:

The Tokens should not be identified or construed as a security or financial instrument of any kind and potential purchasers should only purchase Tokens for its utility and in such quantities as will actually be used by such purchasers in the foreseeable future.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Julia MetaPR
julia@metapr.agency

Sarah MetaPR
sarah@metapr.agency

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Acathia Capital Completes Acquisition of Swedish Life Insurer Futur Pension7.10.2022 11:51:00 CEST | Press release

With the receipt of approvals from the Swedish Financial Supervisory Authority, Acathia Capital has completed the increase of its stake in Futur Pension Försäkrings AB, the most successful life insurer in Sweden. Since 2019, Acathia Capital has been the joint lead investor, together with the Nordic private equity manager Polaris, in this investment, within a group of 5 institutional investors. As a result of the transaction, investment vehicles advised by Acathia have increased their joint stake in Futur Pension from 30% to almost 50%. Futur Pension is a powerful demonstration of how digitalization is fundamentally transforming the insurance business. The fintech, founded in 2000, has already fundamentally transformed the Swedish life insurance market in terms of cost and market share structure. Dr. Thomas Schmitt, managing partner of Acathia Capital, comments: “Futur Pension has increased its market share from 7% to over 11% of premium volume since we have become owners in 2019, makin

EIG’s MidOcean Energy to Acquire Tokyo Gas’ Interests in Portfolio of Four Australian Integrated LNG Projects for US$2.15 Billion7.10.2022 10:44:00 CEST | Press release

MidOcean Energy (“MidOcean”), an LNG company formed and managed by EIG, a leading institutional investor in the global energy and infrastructure sectors, today announced that it has entered into a definitive agreement with Tokyo Gas Co., Ltd (“Tokyo Gas”) to acquire Tokyo Gas’ interests in a portfolio of four Australian integrated LNG projects. Under the terms of the agreement, MidOcean will acquire Tokyo Gas’ interests in Gorgon LNG, Ichthys LNG, Pluto LNG and Queensland Curtis LNG for total cash consideration of US$2.15 billion. These integrated projects span Australia’s western and eastern seaboard and are major suppliers of LNG to Asia, with a diverse set of long-dated take or pay contracts with investment grade counterparties, and to Australia’s domestic gas markets. The portfolio is expected to generate approximately 1 million tonnes per annum of LNG net to MidOcean, production that is underpinned by long-life reserves and a globally competitive cost structure. The portfolio bene

LabGenius Secures Government Innovation Grant to Expand ML-driven Drug Discovery Platform, EVA™7.10.2022 09:00:00 CEST | Press release

LabGenius, a pioneer in the use of machine learning (ML) for antibody engineering, today announced that it has been awarded a highly competitive SMART grant from Innovate UK. Grants from the £25 million fund allow businesses like LabGenius to realize the potential of new ideas by investing in game-changing, commercially viable research and development projects. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221007005023/en/ To date, LabGenius’ EVA platform has been used to co-optimize mono- and multi-specific single domain antibodies for biochemical and bio functional properties, including stability, potency and selective tumor cell killing. This grant will be used to further expand EVA's capabilitiesby accelerating the platform’s ability to optimize antibody-based immune cell engager molecules. Many existing antibody therapeutics have poor selective cell killing profiles, which can result in on-target, off-tumor effects, an

Slate Asset Management Provides Fleet Financing to Move About Group AB to Support Rollout of Electric Vehicles and Charging Infrastructure Across Europe7.10.2022 09:00:00 CEST | Press release

Slate Asset Management (“Slate”), a global alternative investment platform targeting real assets, today announced that it has agreed to provide financing to Move About Group AB (“Move About”), a Swedish electric mobility service, to support the roll out of more than 150 electric vehicles and electric vehicle charging infrastructure throughout Europe. The car funding provided by Slate will be used to bolster Move About’s electric car fleet, which currently owns and operates over 800 electric cars and has more than 71,000 users on its platform. Move About is a Sweden-based electric mobility service that delivers environmentally friendly and cost-effective mobility solutions to over 300 locations across Sweden, Norway, and Germany. Move About has partnered with some of the largest companies across Europe to save tons of carbon dioxide emissions every year. Since it was founded in 2007, Move About has become the largest provider of emission-free carsharing in the Nordic region. Christian S

Valbiotis Accelerates Its Marketing Strategy7.10.2022 07:35:00 CEST | Press release

Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, is accelerating its marketing strategy. Sébastien PELTIER, Chairman of the Valbiotis Board of Directors, states: "Today, we are embarking on a complementary development cycle to commercialize our innovative active substances, with the aim of providing breakthrough solutions for reducing the risk factors of cardio-metabolic diseases. Our new strategy aims to accelerate the growth of Valbiotis and to boost its capacity for innovation using two main levers: firstly, the signing of international partnerships (global or regional) with major players in the nutrition and healthcare sectors, supported by the specialist firm AEC Partners1, and secondly, the company's own marketing of its products on the French market. This dual strategy, creating value, will enable Valbiotis to rapidly tar